{"id":82,"date":"2007-07-20T18:39:46","date_gmt":"2007-07-20T18:39:46","guid":{"rendered":"http:\/\/www.whistleblowerlawyerblog.com\/2007\/07\/pharmaceutical_company_bristol.html"},"modified":"2021-06-11T17:53:59","modified_gmt":"2021-06-11T21:53:59","slug":"pharmaceutical_company_bristol","status":"publish","type":"post","link":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/pharmaceutical_company_bristol\/","title":{"rendered":"Pharmaceutical Company Bristol Settles Massachusetts Lawsuit Over Pricing of Drugs"},"content":{"rendered":"

Alleged Overcharging for Prescription Drugs Leads to $13 Million Settlement in Boston<\/strong><\/p>\n

Pharmaceutical fraud<\/a> harms the Medicare and Medicaid programs–and the citizens who pay for them. Drug companies’ alleged overcharging for prescription drugs has led to fraud investigations and lawsuits by whistleblower attorneys in the past<\/a>. This week, shortly before trial, pharmaceutical manufacturer Bristol-Myers Squibb Co. reportedly agreed to pay $13 million to resolve allegations that it overcharged for its Taxol cancer medicine and other drugs.<\/p>\n

The settlement follows a ruling last month ordering Bristol Myers-Squibb, AstraZeneca Plc and Schering-Plough Corp. to pay damages for allegedly overcharging on drugs by inflating the “average wholesale price” (AWP).<\/a><\/p>\n

Continue reading \u2192<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

Alleged Overcharging for Prescription Drugs Leads to $13 Million Settlement in Boston Pharmaceutical fraud harms the Medicare and Medicaid programs–and the citizens who pay for them. Drug companies’ alleged overcharging for prescription drugs has led to fraud investigations and lawsuits by whistleblower attorneys in the past. This week, shortly before trial, pharmaceutical manufacturer Bristol-Myers Squibb […]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6,8,10],"tags":[],"class_list":["post-82","post","type-post","status-publish","format-standard","hentry","category-health-care-fraud","category-medicare-and-medicaid-fraud","category-pharmaceutical-fraud"],"yoast_head":"\nPharmaceutical Company Bristol Settles Massachusetts Lawsuit Over Pricing of Drugs — Whistleblower Lawyer Blog — July 20, 2007<\/title>\n<meta name=\"description\" content=\"Alleged Overcharging for Prescription Drugs Leads to $13 Million Settlement in Boston Pharmaceutical fraud harms the Medicare and Medicaid programs--and — July 20, 2007\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.finchmccranie.com\/whistleblower-blog\/pharmaceutical_company_bristol\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Pharmaceutical Company Bristol Settles Massachusetts Lawsuit Over Pricing of Drugs — Whistleblower Lawyer Blog — July 20, 2007\" \/>\n<meta name=\"twitter:description\" content=\"Alleged Overcharging for Prescription Drugs Leads to $13 Million Settlement in Boston Pharmaceutical fraud harms the Medicare and Medicaid programs--and — July 20, 2007\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Michael Sullivan\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmaceutical Company Bristol Settles Massachusetts Lawsuit Over Pricing of Drugs — Whistleblower Lawyer Blog — July 20, 2007","description":"Alleged Overcharging for Prescription Drugs Leads to $13 Million Settlement in Boston Pharmaceutical fraud harms the Medicare and Medicaid programs--and — July 20, 2007","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/pharmaceutical_company_bristol\/","twitter_card":"summary_large_image","twitter_title":"Pharmaceutical Company Bristol Settles Massachusetts Lawsuit Over Pricing of Drugs — Whistleblower Lawyer Blog — July 20, 2007","twitter_description":"Alleged Overcharging for Prescription Drugs Leads to $13 Million Settlement in Boston Pharmaceutical fraud harms the Medicare and Medicaid programs--and — July 20, 2007","twitter_misc":{"Written by":"Michael Sullivan","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/pharmaceutical_company_bristol\/#article","isPartOf":{"@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/pharmaceutical_company_bristol\/"},"author":{"name":"Michael Sullivan","@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/#\/schema\/person\/06cb979e5d74ec7f83f73b757da4331f"},"headline":"Pharmaceutical Company Bristol Settles Massachusetts Lawsuit Over Pricing of Drugs","datePublished":"2007-07-20T18:39:46+00:00","dateModified":"2021-06-11T21:53:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/pharmaceutical_company_bristol\/"},"wordCount":222,"articleSection":["Health Care Fraud","Medicare and Medicaid Fraud","Pharmaceutical Fraud"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/pharmaceutical_company_bristol\/","url":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/pharmaceutical_company_bristol\/","name":"Pharmaceutical Company Bristol Settles Massachusetts Lawsuit Over Pricing of Drugs — Whistleblower Lawyer Blog — July 20, 2007","isPartOf":{"@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/#website"},"datePublished":"2007-07-20T18:39:46+00:00","dateModified":"2021-06-11T21:53:59+00:00","author":{"@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/#\/schema\/person\/06cb979e5d74ec7f83f73b757da4331f"},"description":"Alleged Overcharging for Prescription Drugs Leads to $13 Million Settlement in Boston Pharmaceutical fraud harms the Medicare and Medicaid programs--and — July 20, 2007","breadcrumb":{"@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/pharmaceutical_company_bristol\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.finchmccranie.com\/whistleblower-blog\/pharmaceutical_company_bristol\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/pharmaceutical_company_bristol\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/"},{"@type":"ListItem","position":2,"name":"Pharmaceutical Company Bristol Settles Massachusetts Lawsuit Over Pricing of Drugs"}]},{"@type":"WebSite","@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/#website","url":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/","name":"Whistleblower Lawyer Blog","description":"Published by Whistleblower Attorneys \u2014 Finch McCranie, LLP","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/#\/schema\/person\/06cb979e5d74ec7f83f73b757da4331f","name":"Michael Sullivan","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/1c20f28ef8779909ce4423e28badc00a489c680349138c20442a37fb45a0e8cf?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1c20f28ef8779909ce4423e28badc00a489c680349138c20442a37fb45a0e8cf?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1c20f28ef8779909ce4423e28badc00a489c680349138c20442a37fb45a0e8cf?s=96&d=mm&r=g","caption":"Michael Sullivan"},"sameAs":["https:\/\/www.finchmccranie.com\/michael-a-sullivan.html"]}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/posts\/82","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/comments?post=82"}],"version-history":[{"count":1,"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/posts\/82\/revisions"}],"predecessor-version":[{"id":2185,"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/posts\/82\/revisions\/2185"}],"wp:attachment":[{"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/media?parent=82"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/categories?post=82"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/tags?post=82"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}